Suggested Topics within your search.
Suggested Topics within your search.
- Clinical trials
- Statistical methods
- methods
- Research Design 60
- Design 58
- Clinical Trials as Topic 36
- Randomized Controlled Trials as Topic 36
- statistics & numerical data 35
- Research 30
- Adaptive sampling (Statistics) 27
- Models, Statistical 26
- Biostatistics 25
- Bayes Theorem 18
- Dose-Response Relationship, Drug 18
- Drug Dosage Calculations 15
- Drug development 15
- Drugs 14
- Testing 14
- Bayesian statistical decision theory 12
- Biochemical markers 12
- Clinical Trials, Phase I as Topic 12
- Clinical Trials, Phase II as Topic 12
- Antineoplastic Agents 9
- Antineoplastic agents 9
- Biometry 9
- Dose-response relationship 9
- therapeutic use 9
- Data Interpretation, Statistical 8
- Drug Evaluation 8
- Endpoint Determination 8
-
1
Surrogate endpoints, part 1 from definition to meta-analytic framework /
Published 2019Get full text
Series
Electronic Video -
2
Phase II clinical trials traditional approaches /
Published 2018Get full text
Series
Electronic Video -
3
-
4
Patient heterogeneity in dose-finding trials part 1, methods for 2 groups/
Published 2018Get full text
Series
Electronic Video -
5
Patient heterogeneity in dose-finding trials part 2, more than 2 groups /
Published 2018Get full text
Series
Electronic Video -
6
Implementation of adaptive methods in early phase clinical trials
Published 2018Get full text
Series
Electronic Video -
7
-
8
-
9
-
10
Frequentist approaches sample size in adaptive clinical designs /
Published 2017Get full text
Series
Electronic Video -
11
Adaptive clinical trials overview, part 1 of 2 /
Published 2017Get full text
Series
Electronic Video -
12
Adaptive clinical trials conclusion and future directions /
Published 2017Get full text
Series
Electronic Video -
13
Adaptive clinical trials overview, part 2 of 2 /
Published 2017Get full text
Series
Electronic Video -
14
Design early phase drug combination trials software /
Published 2017Get full text
Series
Electronic Video -
15
-
16
-
17
-
18
-
19
-
20
Biomarkers and surrogate endpoints in randomized clinical trials
Published 2016Get full text
Series
Electronic Video